Table 2.
Response | GP group (n=41) | TPF group (n=40) | P value |
---|---|---|---|
No (%) | No (%) | ||
After induction chemotherapy | |||
CR | 32 (78) | 28 (70) | 0.483 |
PR | 9 (22) | 11 (27.5) | |
SD | 0 | 1 (2.5) | |
After IC + CCRT | |||
CR | 38 (92.7) | 34 (85) | 0.271 |
PR | 3 (7.3) | 6 (15) |
Response | GP group (n=41) | TPF group (n=40) | P value |
---|---|---|---|
No (%) | No (%) | ||
After induction chemotherapy | |||
CR | 32 (78) | 28 (70) | 0.483 |
PR | 9 (22) | 11 (27.5) | |
SD | 0 | 1 (2.5) | |
After IC + CCRT | |||
CR | 38 (92.7) | 34 (85) | 0.271 |
PR | 3 (7.3) | 6 (15) |